ALNYLAM PHARMACEUTICALS, INC.·4

Jun 17, 4:47 PM ET

VINCENT JAMES L 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 17, 2010

Insider Transaction Report

Form 4
Period: 2010-06-15
Transactions
  • Exercise/Conversion

    Common Stock

    2010-06-15$7.02/sh+30,000$210,60040,000 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2010-06-1530,00012,100 total
    Exercise: $7.02From: 2006-07-12Exp: 2015-07-12Common Stock (30,000 underlying)
  • Sale

    Common Stock

    2010-06-15$16.00/sh30,000$480,09010,000 total
Footnotes (1)
  • [F1]The stock option vested as to one third of the shares on each of the first, second and third anniversaries of the grant date.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT